Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs
March 22, 2022 at 12:23 PM EDT
Orphazyme A/S(NASDAQ: ORPH) hasdecided to withdraw its European Marketing Application for arimoclomolfor Niemann-Pick ...